HAVCR2 and chronic myelogenous leukemia, BCR-ABL1 positive: Significantly alterations on the expression of tumor recognition (NCRs and NKp80), and immune regulation receptors (LAG-3, TIM-3, and CD137) by NKT-like cells were observed in CML patients.